Viral-Vector-Delivered Anti-Angiogenic Therapies to the Eye

Pathological vessel growth harms vision and may finally lead to vision loss. Anti-angiogenic gene therapy with viral vectors for ocular neovascularization has shown great promise in preclinical studies. Most of the studies have been conducted with different adeno-associated serotype vectors. In addi...

Descripción completa

Detalles Bibliográficos
Autores principales: Koponen, Sanna, Kokki, Emmi, Kinnunen, Kati, Ylä-Herttuala, Seppo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915489/
https://www.ncbi.nlm.nih.gov/pubmed/33562561
http://dx.doi.org/10.3390/pharmaceutics13020219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915489/
https://www.ncbi.nlm.nih.gov/pubmed/33562561
http://dx.doi.org/10.3390/pharmaceutics13020219

Ejemplares similares